Simon Weonsang Ro

1.6k total citations · 1 hit paper
41 papers, 1.1k citations indexed

About

Simon Weonsang Ro is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Simon Weonsang Ro has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Hepatology and 9 papers in Oncology. Recurrent topics in Simon Weonsang Ro's work include Liver physiology and pathology (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer Mechanisms and Therapy (7 papers). Simon Weonsang Ro is often cited by papers focused on Liver physiology and pathology (10 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Cancer Mechanisms and Therapy (7 papers). Simon Weonsang Ro collaborates with scholars based in South Korea, United States and Canada. Simon Weonsang Ro's co-authors include Hyuk Moon, Kwang‐Hyub Han, Bruce Rannala, Do Young Kim, Sook In Chung, Kyung Joo Cho, Kyungjoo Cho, Jung Woo Eun, Suk Woo Nam and Hyun-Jung Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Simon Weonsang Ro

40 papers receiving 1.1k citations

Hit Papers

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma 2021 2026 2022 2024 2021 50 100 150

Peers

Simon Weonsang Ro
Jian Kong China
Hyuk Moon South Korea
Biao Fan China
Shi Zuo China
Saswati Hazra United States
Dali Zhao China
Jian Kong China
Simon Weonsang Ro
Citations per year, relative to Simon Weonsang Ro Simon Weonsang Ro (= 1×) peers Jian Kong

Countries citing papers authored by Simon Weonsang Ro

Since Specialization
Citations

This map shows the geographic impact of Simon Weonsang Ro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Weonsang Ro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Weonsang Ro more than expected).

Fields of papers citing papers by Simon Weonsang Ro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Weonsang Ro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Weonsang Ro. The network helps show where Simon Weonsang Ro may publish in the future.

Co-authorship network of co-authors of Simon Weonsang Ro

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Weonsang Ro. A scholar is included among the top collaborators of Simon Weonsang Ro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Weonsang Ro. Simon Weonsang Ro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moon, Hyuk, et al.. (2025). Kinase suppressor of Ras 1 (KSR1) promotes liver carcinogenesis via activation of the RAS/RAF/MEK/ERK signaling pathway. JHEP Reports. 7(11). 101536–101536. 1 indexed citations
2.
Park, Hyun-Jung, et al.. (2023). Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications. International Journal of Molecular Sciences. 24(18). 13764–13764. 30 indexed citations
3.
Moon, Hyuk, et al.. (2023). Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma. Pharmaceutics. 15(8). 2130–2130. 35 indexed citations
5.
Moon, Hyuk, et al.. (2022). Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways. BMC Cancer. 22(1). 423–423. 14 indexed citations
6.
Cho, Kyung Joo, et al.. (2021). Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer. Translational Oncology. 14(9). 101158–101158. 7 indexed citations
7.
Moon, Hyuk & Simon Weonsang Ro. (2021). Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma. PubMed. 21(1). 1–11. 10 indexed citations
8.
Cho, Kyungjoo, Hyuk Moon, Sang Hyun Seo, Simon Weonsang Ro, & Beom Kyung Kim. (2021). Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences. 22(24). 13214–13214. 7 indexed citations
10.
Moon, Hyuk, Sook In Chung, Kyung Joo Cho, et al.. (2017). Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Gastroenterology. 153(5). 1378–1391.e6. 75 indexed citations
11.
Ro, Simon Weonsang, et al.. (2016). Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma. Chinese Journal of Cancer Research. 28(3). 380–382. 4 indexed citations
12.
Chung, Sook In, Hyuk Moon, Kyung Joo Cho, et al.. (2016). Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background. BMC Gastroenterology. 16(1). 13–13. 18 indexed citations
13.
Calvisi, Diego F., Hyuk Moon, Silvia Ribback, et al.. (2015). Transgenic mouse model expressing P53R172H, luciferase, EGFP and KRASG12D in a single open reading frame for live imaging of tumor. Scientific Reports. 5(1). 8053–8053. 10 indexed citations
14.
Chung, Sook In, Hyuk Moon, Kyung Joo Cho, et al.. (2015). Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model. Journal of Hepatology. 64(3). 618–627. 95 indexed citations
15.
Kim, Do Young, Sook In Chung, Simon Weonsang Ro, et al.. (2013). Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats. APOPTOSIS. 18(12). 1481–1491. 14 indexed citations
16.
Jung, Sun-Young, et al.. (2013). Sleeping Beauty transposon system harboring HRAS, c-Myc and shp53 induces sarcomatoid carcinomas in mouse skin. Oncology Reports. 29(4). 1293–1298. 7 indexed citations
17.
Ahn, Sang Hoon, Do Young Kim, Sook In Chung, et al.. (2013). Investigation of Oncogenic Cooperation in Simple Liver-Specific Transgenic Mouse Models Using Noninvasive In Vivo Imaging. PLoS ONE. 8(3). e59869–e59869. 34 indexed citations
18.
Dorrell, Craig, Laura Erker, Stephanie Abraham, et al.. (2008). Surface markers for the murine oval cell response†. Hepatology. 48(4). 1282–1291. 71 indexed citations
19.
Ro, Simon Weonsang & Bruce Rannala. (2005). Evidence from the stop‐EGFP mouse supports a niche‐sharing model of epidermal proliferative units. Experimental Dermatology. 14(11). 838–843. 23 indexed citations
20.
Ro, Simon Weonsang. (2004). Magnifying Stem Cell Lineages: The Stop-EGFP Mouse. Cell Cycle. 3(10). 1246–1249. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026